This technical brief sets out guiding principles and targeted interventions to reduce the risk of HIV transmission and facilitate access to healthcare for transgender people deprived of liberty.
The NZ Drug Foundation and Helen Clark Foundation discuss use patterns and markets in Aotearoa / New Zealand, related harms, current regulations and how to reduce harms through psychosocial, cultural, and pharmacological approaches.
The CESeC presents data on the costs of drug prohibition for seven institutions of the criminal justice systems of the states of Rio de Janeiro and São Paulo.
C-EHRN provides an update on the work to ensure access to harm reduction services and other forms of care and support for populations in situations of vulnerability in Ukraine and neighbouring countries.
Peet et al. identify an increase in the out of pocket costs for naloxone, indicating an increasingly substantial barrier to naloxone access for uninsured patients in the US.
Macmadu et al. emphasise the need for increased investment and integration of mental health and bereavement services for people who use drugs, with findings showing that overdoses within social networks can have severe consequences for individual overdose risk.
Fontecha and Walker allude to a lack of formal economic opportunities, familial traditions and armed groups pressure as key factors that motivate young people's involvement in informal coca growing.
